{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:12:46Z","timestamp":1792843966744,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000278","name":"Department for International Development, UK Government","doi-asserted-by":"publisher","award":["300341-115"],"award-info":[{"award-number":["300341-115"]}],"id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC_17167"],"award-info":[{"award-number":["MC_PC_17167"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["899670"],"award-info":[{"award-number":["899670"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["mr\/s03398x\/1"],"award-info":[{"award-number":["mr\/s03398x\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["200517\/Z\/16\/Z"],"award-info":[{"award-number":["200517\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Antivenom is currently the first-choice treatment for snakebite envenoming. However, only a low proportion of antivenom immunoglobulins are specific to venom toxins, resulting in poor dose efficacy and potency. We sought to investigate whether linear venom epitopes displayed on virus like particles can stimulate an antibody response capable of recognising venom toxins from diverse medically important species. Bioinformatically-designed epitopes, corresponding to predicted conserved regions of group I phospholipase A<jats:sub>2<\/jats:sub> and three finger toxins, were engineered for display on the surface of hepatitis B core antigen virus like particles and used to immunise female CD1 mice over a 14\u00a0weeks. Antibody responses to all venom epitope virus like particles were detectable by ELISA by the end of the immunisation period, although total antibody and epitope specific antibody titres were variable against the different epitope immunogens. Immunoblots using pooled sera demonstrated recognition of various venom components in a diverse panel of six elapid venoms, representing three continents and four genera. Insufficient antibody yields precluded a thorough assessment of the neutralising ability of the generated antibodies, however we were able to test polyclonal anti-PLA<jats:sub>2<\/jats:sub> IgG from three animals against the PLA\ufeff<jats:sub>2<\/jats:sub> activity of <jats:italic>Naja nigricollis<\/jats:italic> venom, all of which showed no neutralising ability. This study demonstrates proof-of-principle that virus like particles engineered to display conserved toxin linear epitopes can elicit specific antibody responses in mice which are able to recognise a geographically broad range of elapid venoms.<\/jats:p>","DOI":"10.1038\/s41598-022-13376-x","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T09:03:05Z","timestamp":1657011785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Virus-like particles displaying conserved toxin epitopes stimulate polyspecific, murine antibody responses capable of snake venom recognition"],"prefix":"10.1038","volume":"12","author":[{"given":"Stefanie K.","family":"Menzies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte A.","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard","family":"Crittenden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Edge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaffer","family":"Alsolaiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Casewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Ainsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"key":"13376_CR1","doi-asserted-by":"publisher","first-page":"17063","DOI":"10.1038\/nrdp.2017.63","volume":"3","author":"JM Guti\u00e9rrez","year":"2017","unstructured":"Guti\u00e9rrez, J. M. et al. Snakebite envenoming. Nat. Rev. Dis. Prim. 3, 17063 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"13376_CR2","doi-asserted-by":"publisher","first-page":"e569","DOI":"10.1371\/journal.pntd.0000569","volume":"3","author":"RA Harrison","year":"2009","unstructured":"Harrison, R. A., Hargreaves, A., Wagstaff, S. C., Faragher, B. & Lalloo, D. G. Snake envenoming: A disease of poverty. PLoS Negl. Trop. Dis. 3, e569 (2009).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"13376_CR3","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2004.71.234","author":"SK Sharma","year":"2004","unstructured":"Sharma, S. K. et al. Impact of snake bites and determinants of fatal outcomes in Southeastern Nepal. Am. J. Trop. Med. Hyg. https:\/\/doi.org\/10.4269\/ajtmh.2004.71.234 (2004).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"13376_CR4","doi-asserted-by":"publisher","DOI":"10.22605\/RRH3496","author":"G Iliyasu","year":"2015","unstructured":"Iliyasu, G. et al. Effect of distance and delay in access to care on outcome of snakebite in rural north-eastern Nigeria. Rural Remote Health https:\/\/doi.org\/10.22605\/RRH3496 (2015).","journal-title":"Rural Remote Health"},{"key":"13376_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.trstmh.2007.11.006","volume":"102","author":"LE Visser","year":"2008","unstructured":"Visser, L. E. et al. Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: The importance of quality surveillance. Trans. R. Soc. Trop. Med. Hyg. 102, 445\u2013450 (2008).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"13376_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1371\/journal.pone.0080090","volume":"8","author":"S Vaiyapuri","year":"2013","unstructured":"Vaiyapuri, S. et al. Snakebite and its socio-economic impact on the rural population of Tamil Nadu, India. PLoS ONE 8, 10\u201313 (2013).","journal-title":"PLoS ONE"},{"key":"13376_CR7","volume-title":"Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins","author":"World Health Organization (WHO)","year":"2018","unstructured":"World Health Organization (WHO). Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins (WHO, 2018)."},{"key":"13376_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0140-6736(09)61754-2","volume":"375","author":"DA Warrell","year":"2010","unstructured":"Warrell, D. A. Snake bite. Lancet 375, 77\u201388 (2010).","journal-title":"Lancet"},{"key":"13376_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxicon.2018.05.001","volume":"150","author":"DJ Williams","year":"2018","unstructured":"Williams, D. J., Habib, A. G. & Warrell, D. A. Clinical studies of the effectiveness and safety of antivenoms. Toxicon 150, 1\u201310 (2018).","journal-title":"Toxicon"},{"key":"13376_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3390\/toxins9040143","volume":"9","author":"A Silva","year":"2017","unstructured":"Silva, A., Hodgson, W. C. & Isbister, G. K. Antivenom for neuromuscular paralysis resulting from snake envenoming. Toxins (Basel) 9, 143 (2017).","journal-title":"Toxins (Basel)"},{"key":"13376_CR11","doi-asserted-by":"publisher","first-page":"e0005612","DOI":"10.1371\/journal.pntd.0005612","volume":"11","author":"E Alirol","year":"2017","unstructured":"Alirol, E. et al. Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal. PLoS Negl. Trop. Dis. 11, e0005612 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"13376_CR12","doi-asserted-by":"publisher","first-page":"e2302","DOI":"10.1371\/journal.pntd.0002302","volume":"7","author":"UK Ranawaka","year":"2013","unstructured":"Ranawaka, U. K., Lalloo, D. G. & de Silva, H. J. Neurotoxicity in snakebite\u2014The limits of our knowledge. PLoS Negl. Trop. Dis. 7, e2302 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"13376_CR13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2165\/00003088-200342080-00002","volume":"42","author":"JM Guti\u00e9rrez","year":"2003","unstructured":"Guti\u00e9rrez, J. M., Le\u00f3n, G. & Lomonte, B. Pharmacokinetic\u2013pharmacodynamic relationships of immunoglobulin therapy for envenomation. Clin. Pharmacokinet. 42, 721\u2013741 (2003).","journal-title":"Clin. Pharmacokinet."},{"key":"13376_CR14","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3390\/toxins12090528","volume":"12","author":"C Knudsen","year":"2020","unstructured":"Knudsen, C. et al. Novel snakebite therapeutics must be tested in appropriate rescue models to robustly assess their preclinical efficacy. Toxins (Basel) 12, 528 (2020).","journal-title":"Toxins (Basel)"},{"key":"13376_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.toxicon.2018.03.004","volume":"146","author":"AH Laustsen","year":"2018","unstructured":"Laustsen, A. H. et al. Pros and cons of different therapeutic antibody formats for recombinant antivenom development. Toxicon 146, 151\u2013175 (2018).","journal-title":"Toxicon"},{"key":"13376_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.toxicon.2018.06.084","volume":"151","author":"G Le\u00f3n","year":"2018","unstructured":"Le\u00f3n, G. et al. Current technology for the industrial manufacture of snake antivenoms. Toxicon 151, 63\u201373 (2018).","journal-title":"Toxicon"},{"key":"13376_CR17","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.jprot.2011.06.019","volume":"74","author":"RA Harrison","year":"2011","unstructured":"Harrison, R. A. et al. Research strategies to improve snakebite treatment: Challenges and progress. J. Proteom. 74, 1768\u20131780 (2011).","journal-title":"J. Proteom."},{"key":"13376_CR18","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.vaccine.2003.09.046","volume":"22","author":"RA Harrison","year":"2004","unstructured":"Harrison, R. A. Development of venom toxin-specific antibodies by DNA immunisation: Rationale and strategies to improve therapy of viper envenoming. Vaccine 22, 1648\u20131655 (2004).","journal-title":"Vaccine"},{"key":"13376_CR19","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.4269\/ajtmh.2010.09-0733","volume":"82","author":"JJ Calvete","year":"2010","unstructured":"Calvete, J. J. et al. Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa. Am. J. Trop. Med. Hyg. 82, 1194\u20131201 (2010).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"13376_CR20","doi-asserted-by":"publisher","first-page":"9205","DOI":"10.1073\/pnas.1405484111","volume":"111","author":"NR Casewell","year":"2014","unstructured":"Casewell, N. R. et al. Medically important differences in snake venom composition are dictated by distinct postgenomic mechanisms. Proc. Natl. Acad. Sci. U. S. A. 111, 9205\u20139210 (2014).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"13376_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/toxins8040086","volume":"8","author":"KY Tan","year":"2016","unstructured":"Tan, K. Y., Tan, C. H., Fung, S. Y. & Tan, N. H. Neutralization of the principal toxins from the venoms of thai naja kaouthia and malaysian hydrophis schistosus: Insights into toxin-specific neutralization by two different antivenoms. Toxins (Basel) 8, 86 (2016).","journal-title":"Toxins (Basel)"},{"key":"13376_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/toxins9050163","volume":"9","author":"JM Guti\u00e9rrez","year":"2017","unstructured":"Guti\u00e9rrez, J. M. et al. Preclinical evaluation of the efficacy of antivenoms for snakebite envenoming: State-of-the-art and challenges ahead. Toxins (Basel) 9, 1\u201322 (2017).","journal-title":"Toxins (Basel)"},{"key":"13376_CR23","doi-asserted-by":"publisher","first-page":"e851","DOI":"10.1371\/journal.pntd.0000851","volume":"4","author":"NR Casewell","year":"2010","unstructured":"Casewell, N. R. et al. Pre-clinical assays predict Pan-African Echis viper efficacy for a species-specific antivenom. PLoS Negl. Trop. Dis. 4, e851 (2010).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"13376_CR24","doi-asserted-by":"publisher","first-page":"e0007059","DOI":"10.1371\/journal.pntd.0007059","volume":"13","author":"DJ Williams","year":"2019","unstructured":"Williams, D. J. et al. Strategy for a globally coordinated response to a priority neglected tropical disease: Snakebite envenoming. PLoS Negl. Trop. Dis. 13, e0007059 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"13376_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/trstmh\/try134","author":"RA Harrison","year":"2019","unstructured":"Harrison, R. A., Casewell, N. R., Ainsworth, S. A. & Lalloo, D. G. The time is now: A call for action to translate recent momentum on tackling tropical snakebite into sustained benefit for victims. Trans. R. Soc. Trop. Med. Hyg. https:\/\/doi.org\/10.1093\/trstmh\/try134 (2019).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"13376_CR26","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3390\/toxins10110452","volume":"10","author":"E Berm\u00fadez-M\u00e9ndez","year":"2018","unstructured":"Berm\u00fadez-M\u00e9ndez, E. et al. Innovative immunization strategies for antivenom development. Toxins 10, 452 (2018).","journal-title":"Toxins"},{"key":"13376_CR27","doi-asserted-by":"publisher","first-page":"0832","DOI":"10.1371\/journal.pmed.0030184","volume":"3","author":"SC Wagstaff","year":"2006","unstructured":"Wagstaff, S. C., Laing, G. D., Theakston, R. D. G., Papaspyridis, C. & Harrison, R. A. Bioinformatics and multiepitope DNA immunization to design rational snake antivenom. PLoS Med. 3, 0832\u20130844 (2006).","journal-title":"PLoS Med."},{"key":"13376_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/toxins8120351","volume":"8","author":"RA Harrison","year":"2016","unstructured":"Harrison, R. A. & Guti\u00e9rrez, J. M. Priority actions and progress to substantially and sustainably reduce the mortality, morbidity and socioeconomic burden of tropical snakebite. Toxins (Basel) 8, 351 (2016).","journal-title":"Toxins (Basel)"},{"key":"13376_CR29","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/toxins9090290","volume":"9","author":"T Tasoulis","year":"2017","unstructured":"Tasoulis, T. & Isbister, G. K. A review and database of snake venom proteomes. Toxins (Basel) 9, 290 (2017).","journal-title":"Toxins (Basel)"},{"key":"13376_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66657-8","author":"K Ratanabanangkoon","year":"2020","unstructured":"Ratanabanangkoon, K. et al. A pan-specific antiserum produced by a novel immunization strategy shows a high spectrum of neutralization against neurotoxic snake venoms. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-020-66657-8 (2020).","journal-title":"Sci. Rep."},{"key":"13376_CR31","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/toxins13080556","volume":"13","author":"B-S Liu","year":"2021","unstructured":"Liu, B.-S. et al. Development of a broad-spectrum antiserum against cobra venoms using recombinant three-finger toxins. Toxins 13, 556 (2021).","journal-title":"Toxins"},{"key":"13376_CR32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.toxicon.2008.05.023","volume":"52","author":"G Azofeifa-Cordero","year":"2008","unstructured":"Azofeifa-Cordero, G., Arce-Estrada, V., Flores-D\u00edaz, M. & Alape-Gir\u00f3n, A. Immunization with cDNA of a novel P-III type metalloproteinase from the rattlesnake Crotalus durissus durissus elicits antibodies which neutralize 69% of the hemorrhage induced by the whole venom. Toxicon 52, 302\u2013308 (2008).","journal-title":"Toxicon"},{"key":"13376_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-11639-2","volume":"10","author":"G de la Rosa","year":"2019","unstructured":"de la Rosa, G. et al. Horse immunization with short-chain consensus \u03b1-neurotoxin generates antibodies against broad spectrum of elapid venomous species. Nat. Commun. 10, 1\u20138 (2019).","journal-title":"Nat. Commun."},{"key":"13376_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0004484","volume":"10","author":"HR Ramos","year":"2016","unstructured":"Ramos, H. R. et al. A heterologous multiepitope DNA prime\/recombinant protein boost immunisation strategy for the development of an antiserum against Micrurus corallinus (coral snake) venom. PLoS Negl. Trop. Dis. 10, 1\u201319 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"13376_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.toxicon.2014.10.015","volume":"93","author":"KL Castro","year":"2015","unstructured":"Castro, K. L. et al. Identification and characterization of B-cell epitopes of 3FTx and PLA2 toxins from Micrurus corallinus snake venom. Toxicon 93, 51\u201360 (2015).","journal-title":"Toxicon"},{"key":"13376_CR36","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.toxicon.2008.11.009","volume":"53","author":"R Cardoso","year":"2009","unstructured":"Cardoso, R. et al. Peptide mimicking antigenic and immunogenic epitope of neuwiedase from Bothrops neuwiedi snake venom. Toxicon 53, 254\u2013261 (2009).","journal-title":"Toxicon"},{"key":"13376_CR37","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/vaccines2030515","volume":"2","author":"W Li","year":"2014","unstructured":"Li, W., Joshi, M. D., Singhania, S., Ramsey, K. H. & Murthy, A. K. Peptide vaccine: Progress and challenges. Vaccines 2, 515\u2013536 (2014).","journal-title":"Vaccines"},{"key":"13376_CR38","doi-asserted-by":"publisher","unstructured":"Tagliamonte, M., Tornesello, M. L., Buonaguro, F. M. & Buonaguro, L. Virus-like particles. In Micro- and Nanotechnology in Vaccine Development (William Andrew publications) (Eds. Mariusz Skwarczynski & Istvan Toth) (2017).https:\/\/doi.org\/10.1016\/B978-0-323-39981-4.00011-7.","DOI":"10.1016\/B978-0-323-39981-4.00011-7"},{"key":"13376_CR39","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.copbio.2013.02.008","volume":"24","author":"WA Rodr\u00edguez-Limas","year":"2013","unstructured":"Rodr\u00edguez-Limas, W. A., Sekar, K. & Tyo, K. E. J. Virus-like particles: The future of microbial factories and cell-free systems as platforms for vaccine development. Curr. Opin. Biotechnol. 24, 1089\u20131093 (2013).","journal-title":"Curr. Opin. Biotechnol."},{"key":"13376_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.coviro.2016.03.001","volume":"18","author":"KM Frietze","year":"2016","unstructured":"Frietze, K. M., Peabody, D. S. & Chackerian, B. Engineering virus-like particles as vaccine platforms. Curr. Opin. Virol. 18, 44\u201349 (2016).","journal-title":"Curr. Opin. Virol."},{"key":"13376_CR41","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/bit.25159","volume":"111","author":"LHL Lua","year":"2014","unstructured":"Lua, L. H. L. et al. Bioengineering virus-like particles as vaccines. Biotechnol. Bioeng. 111, 425\u2013440 (2014).","journal-title":"Biotechnol. Bioeng."},{"key":"13376_CR42","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1586\/erv.09.121","volume":"8","author":"DC Whitacre","year":"2009","unstructured":"Whitacre, D. C., Lee, B. O. & Milich, D. R. Use of hepadnavirus core proteins as vaccine platforms. Expert Rev. Vaccines 8, 1565\u20131573 (2009).","journal-title":"Expert Rev. Vaccines"},{"key":"13376_CR43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1586\/erv.12.150","volume":"12","author":"K Roose","year":"2013","unstructured":"Roose, K., Baets, S. D., Schepens, B. & Saelens, X. Hepatitis B core-based virus-like particles to present heterologous epitopes. Expert Rev. Vaccines 12, 183\u2013198 (2013).","journal-title":"Expert Rev. Vaccines"},{"key":"13376_CR44","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1128\/JVI.01848-13","volume":"88","author":"X Ye","year":"2014","unstructured":"Ye, X. et al. Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms. J. Virol. 88, 72\u201381 (2014).","journal-title":"J. Virol."},{"key":"13376_CR45","doi-asserted-by":"publisher","first-page":"e0191277","DOI":"10.1371\/journal.pone.0191277","volume":"13","author":"AR Kim","year":"2018","unstructured":"Kim, A. R. et al. Protection induced by virus-like particle vaccine containing tandem repeat gene of respiratory syncytial virus G protein. PLoS ONE 13, e0191277 (2018).","journal-title":"PLoS ONE"},{"key":"13376_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"M Yang","year":"2017","unstructured":"Yang, M., Lai, H., Sun, H. & Chen, Q. Virus-like particles that display Zika virus envelope protein domain III induce potent neutralizing immune responses in mice. Sci. Rep. 7, 1\u201312 (2017).","journal-title":"Sci. Rep."},{"key":"13376_CR47","doi-asserted-by":"publisher","first-page":"e0008366","DOI":"10.1371\/journal.pntd.0008366","volume":"14","author":"KE Krause","year":"2020","unstructured":"Krause, K. E. et al. An interactive database for the investigation of high-density peptide microarray guided interaction patterns and antivenom cross-reactivity. PLoS Negl. Trop. Dis. 14, e0008366 (2020).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"13376_CR48","doi-asserted-by":"publisher","unstructured":"Zhou, X., Manjunatha Kini, R. & Doley, R. Snake venom phospholipase A2 enzymes. In Handbook of Venoms and Toxins of Reptiles (Taylor and Francis.) (Eds Stephen P Mackessy) (2009).https:\/\/doi.org\/10.1201\/9781420008661.ch8.","DOI":"10.1201\/9781420008661.ch8"},{"key":"13376_CR49","doi-asserted-by":"publisher","first-page":"8855","DOI":"10.1021\/acsnano.8b02805","volume":"12","author":"TUJ Bruun","year":"2018","unstructured":"Bruun, T. U. J., Andersson, A. M. C., Draper, S. J. & Howarth, M. Engineering a rugged nanoscaffold to enhance plug-and-display vaccination. ACS Nano 12, 8855\u20138866 (2018).","journal-title":"ACS Nano"},{"key":"13376_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-53208-z","volume":"9","author":"L Yenkoidiok-Douti","year":"2019","unstructured":"Yenkoidiok-Douti, L., Williams, A. E., Canepa, G. E., Molina-Cruz, A. & Barillas-Mury, C. Engineering a virus-like particle as an antigenic platform for a Pfs47-targeted malaria transmission-blocking vaccine. Sci. Rep. 9, 1\u20139 (2019).","journal-title":"Sci. Rep."},{"key":"13376_CR51","doi-asserted-by":"crossref","unstructured":"Marini, A. et al. A universal plug-and-display vaccine carrier based on HBsAg VLP to maximize effective antibody response. Front. Immunol. 10, 2931 (2019).","DOI":"10.3389\/fimmu.2019.02931"},{"key":"13376_CR52","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jprot.2015.02.002","volume":"119","author":"AH Laustsen","year":"2015","unstructured":"Laustsen, A. H., Lomonte, B., Lohse, B., Fern\u00e1ndez, J. & Guti\u00e9rrez, J. M. Unveiling the nature of black mamba (Dendroaspis polylepis) venom through venomics and antivenom immunoprofiling: Identification of key toxin targets for antivenom development. J. Proteom. 119, 126\u2013142 (2015).","journal-title":"J. Proteom."},{"key":"13376_CR53","doi-asserted-by":"publisher","first-page":"e0005969","DOI":"10.1371\/journal.pntd.0005969","volume":"11","author":"RA Harrison","year":"2017","unstructured":"Harrison, R. A. et al. Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa. PLoS Negl. Trop. Dis. 11, e0005969 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"13376_CR54","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jprot.2008.10.003","volume":"71","author":"SC Wagstaff","year":"2009","unstructured":"Wagstaff, S. C., Sanz, L., Ju\u00e1rez, P., Harrison, R. A. & Calvete, J. J. Combined snake venomics and venom gland transcriptomic analysis of the ocellated carpet viper, Echis ocellatus. J. Proteom. 71, 609\u2013623 (2009).","journal-title":"J. Proteom."},{"key":"13376_CR55","doi-asserted-by":"publisher","unstructured":"Rajagopalan, N., Manjunatha Kini, R., Doley, R. & Hegde, R. Snake venom three-finger toxins. In Handbook of Venoms and Toxins of Reptiles (Taylor and Francis.) (Eds Stephen P Mackessy) (2009).https:\/\/doi.org\/10.1201\/9781420008661.sec3.","DOI":"10.1201\/9781420008661.sec3"},{"key":"13376_CR56","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1007\/s40264-015-0350-4","volume":"38","author":"N Petrovsky","year":"2015","unstructured":"Petrovsky, N. Comparative safety of vaccine adjuvants: A summary of current evidence and future needs. Drug Saf. 38, 1059 (2015).","journal-title":"Drug Saf."},{"key":"13376_CR57","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.toxicon.2010.03.025","volume":"56","author":"DAN Cook","year":"2010","unstructured":"Cook, D. A. N. et al. Analysis of camelid IgG for antivenom development: Serological responses of venom-immunised camels to prepare either monospecific or polyspecific antivenoms for West Africa. Toxicon 56, 363\u2013372 (2010).","journal-title":"Toxicon"},{"key":"13376_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/protein\/gzq069","volume":"24","author":"MG Mateu","year":"2011","unstructured":"Mateu, M. G. Virus engineering: Functionalization and stabilization. Protein Eng. Des. Sel. 24, 53\u201363 (2011).","journal-title":"Protein Eng. Des. Sel."},{"key":"13376_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/srep19234","author":"KD Brune","year":"2016","unstructured":"Brune, K. D. et al. Plug-and-display: Decoration of virus-like particles via isopeptide bonds for modular immunization. Sci. Rep. https:\/\/doi.org\/10.1038\/srep19234 (2016).","journal-title":"Sci. Rep."},{"key":"13376_CR60","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nature18010","volume":"535","author":"Y Hsia","year":"2016","unstructured":"Hsia, Y. et al. Design of a hyperstable 60-subunit protein icosahedron. Nature 535, 136\u2013139 (2016).","journal-title":"Nature"},{"key":"13376_CR61","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.molimm.2018.10.019","volume":"104","author":"DA Molina Molina","year":"2018","unstructured":"Molina Molina, D. A. et al. Identification of a linear B-cell epitope in the catalytic domain of bothropasin, a metalloproteinase from Bothrops jararaca snake venom. Mol. Immunol. 104, 20\u201326 (2018).","journal-title":"Mol. Immunol."},{"key":"13376_CR62","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1016\/j.vaccine.2013.03.048","volume":"31","author":"TM Mendes","year":"2013","unstructured":"Mendes, T. M. et al. Generation and characterization of a recombinant chimeric protein (rCpLi) consisting of B-cell epitopes of a dermonecrotic protein from Loxosceles intermedia spider venom. Vaccine 31, 2749\u20132755 (2013).","journal-title":"Vaccine"},{"key":"13376_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/srep36629","author":"M Engmark","year":"2016","unstructured":"Engmark, M. et al. High-throughput immuno-profiling of mamba (Dendroaspis) venom toxin epitopes using high-density peptide microarrays. Sci. Rep. https:\/\/doi.org\/10.1038\/srep36629 (2016).","journal-title":"Sci. Rep."},{"key":"13376_CR64","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1126\/science.abb9303","volume":"371","author":"TD Kazandjian","year":"2021","unstructured":"Kazandjian, T. D. et al. Convergent evolution of pain-inducing defensive venom components in spitting cobras. Science (80-) 371, 386\u2013390 (2021).","journal-title":"Science (80-)"},{"key":"13376_CR65","unstructured":"IAVI\/Wellcome. Expanding Access to Monoclonal Antibody-Based Products: A Global Call to Action. https:\/\/wellcome.org\/sites\/default\/files\/expanding-access-to-monoclonal-antibody-based-products.pdf (2020)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13376-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13376-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13376-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T06:17:54Z","timestamp":1669357074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13376-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13376"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-13376-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,5]]},"assertion":[{"value":"2 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11328"}}